BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 18508365)

  • 1. Regarding the risk for development of surgical site infections and bacterial prophylaxis in liver transplantation.
    Kusne S
    Liver Transpl; 2008 Jun; 14(6):747-9. PubMed ID: 18508365
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of antibiotic prophylaxis on the risk of surgical site infection in orthotopic liver transplant.
    Asensio A; Ramos A; Cuervas-Mons V; Cordero E; Sánchez-Turrión V; Blanes M; Cervera C; Gavalda J; Aguado JM; Torre-Cisneros J;
    Liver Transpl; 2008 Jun; 14(6):799-805. PubMed ID: 18508358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [When is antibiotic prophylaxis required?].
    Hansis M
    Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():708-12. PubMed ID: 9101974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of surgical site infection.
    Kirby JP; Mazuski JE
    Surg Clin North Am; 2009 Apr; 89(2):365-89, viii. PubMed ID: 19281889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting posttransplantation infection risk with gene polymorphisms.
    Perkins JD
    Liver Transpl; 2006 Mar; 12(3):488-9. PubMed ID: 16598850
    [No Abstract]   [Full Text] [Related]  

  • 6. Surgical site infection after liver transplantation: risk factors and association with graft loss or death.
    Hellinger WC; Crook JE; Heckman MG; Diehl NN; Shalev JA; Zubair AC; Willingham DL; Hewitt WR; Grewal HP; Nguyen JH; Hughes CB
    Transplantation; 2009 May; 87(9):1387-93. PubMed ID: 19424041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vancomycin versus cefazolin prophylaxis for cerebrospinal shunt placement in a hospital with a high prevalence of meticillin-resistant Staphylococcus aureus.
    Tacconelli E; Cataldo MA; Albanese A; Tumbarello M; Arduini E; Spanu T; Fadda G; Anile C; Maira G; Federico G; Cauda R
    J Hosp Infect; 2008 Aug; 69(4):337-44. PubMed ID: 18602187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotic prophylaxis in dermatologic surgery: advisory statement 2008.
    Wright TI; Baddour LM; Berbari EF; Roenigk RK; Phillips PK; Jacobs MA; Otley CC
    J Am Acad Dermatol; 2008 Sep; 59(3):464-73. PubMed ID: 18694679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevention of postoperative wound infections: repeatedly evaluating facility specific measures].
    Loczenski B
    Pflege Z; 2008 Jan; 61(1):19-23. PubMed ID: 18251191
    [No Abstract]   [Full Text] [Related]  

  • 10. Decrease of deep sternal surgical site infection rates after cardiac surgery by a comprehensive infection control program.
    Graf K; Sohr D; Haverich A; Kühn C; Gastmeier P; Chaberny IF
    Interact Cardiovasc Thorac Surg; 2009 Aug; 9(2):282-6. PubMed ID: 19416962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of risk-stratified, protocol-based perioperative chemoprophylaxis on nosocomial infection rates in a series of 31 927 consecutive neurosurgical procedures (1994-2006).
    Sharma MS; Vohra A; Thomas P; Kapil A; Suri A; Chandra PS; Kale SS; Mahapatra AK; Sharma BS
    Neurosurgery; 2009 Jun; 64(6):1123-30; discussion 1130-1. PubMed ID: 19487892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy of ceftriaxone administered for prophylaxis of postoperative infection and infectious diseases in obstetrics and gynecology.
    Chimura T
    J Chemother; 1989 Jul; 1(4 Suppl):1039-41. PubMed ID: 16312762
    [No Abstract]   [Full Text] [Related]  

  • 13. [Rejection and infection in liver transplantation].
    Díaz Fernández MC; Jara Vega P; de la Vega Bueno A; Hierro Llanillo L; Camarena Grande C; Gámez Arance M; Murcia Zoriza J
    An Esp Pediatr; 1989 Sep; 31 Suppl 39():86-8. PubMed ID: 2490339
    [No Abstract]   [Full Text] [Related]  

  • 14. Vascular surgical site infection: risk factors and preventive measures.
    Bandyk DF
    Semin Vasc Surg; 2008 Sep; 21(3):119-23. PubMed ID: 18774446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic mezlocillin in vaginal hysterectomy: a prospective, randomized study.
    Conturso R; Radaelli L; Turtulici P; Alegente G; De Lalla F
    J Chemother; 1989 Jul; 1(4 Suppl):1033-4. PubMed ID: 16312759
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical impact and risk factors for percutaneous gastrostomy wound infections due to resistant organisms.
    Mahadeva S; Khoo BL; Khoo PS; Malik A; Hilmi I; Qua CS; Wong CH; Goh KL
    Int J Infect Dis; 2008 Nov; 12(6):e149-50. PubMed ID: 18635384
    [No Abstract]   [Full Text] [Related]  

  • 17. Mezlocillin versus cefotetan in abdominal hysterectomy prophylaxis: a prospective randomized study. Preliminary results.
    Conturso R; Bucciero A; Marcolli R; Alegente G; Regallo M; Tagliabue R; Molteni E; De Lalla F
    J Chemother; 1989 Jul; 1(4 Suppl):1035-7. PubMed ID: 16312760
    [No Abstract]   [Full Text] [Related]  

  • 18. Staphylococcal surgical site infections.
    Anderson DJ; Kaye KS
    Infect Dis Clin North Am; 2009 Mar; 23(1):53-72. PubMed ID: 19135916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ways of improving bacteriological control in operating rooms].
    Nikishin VK; Aronova RA; Borisova IB; Trunilina RA
    Vestn Khir Im I I Grek; 1984 Mar; 132(3):129-30. PubMed ID: 6232750
    [No Abstract]   [Full Text] [Related]  

  • 20. Protecting patients from harm: reducing methicillin-resistant Staphylococcus aureus infections.
    Yamamoto L; Marten M
    Adv Skin Wound Care; 2008 Jul; 21(7):335-40; quiz 341-2. PubMed ID: 18600076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.